4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives $30.50 Average Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Related Keywords